The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2025

Filed:

Oct. 08, 2020
Applicant:

Ads Therapeutics Llc, Reno, NV (US);

Inventors:

Jinsong Ni, Irvine, CA (US);

Rong Yang, Mission Viejo, CA (US);

Assignee:

ADS Therapeutics LLC, Irvine, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 9/00 (2006.01); A61K 9/08 (2006.01); A61K 31/496 (2006.01); A61K 47/64 (2017.01); A61K 47/68 (2017.01); C07K 16/00 (2006.01); C07K 16/22 (2006.01); A61K 47/46 (2006.01);
U.S. Cl.
CPC ...
A61K 47/6803 (2017.08); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/496 (2013.01); A61K 39/3955 (2013.01); A61K 47/6845 (2017.08); A61K 47/6849 (2017.08); C07K 16/00 (2013.01); C07K 16/22 (2013.01); A61K 47/46 (2013.01); C07K 2317/24 (2013.01);
Abstract

A method of producing synergistic and enhanced efficacy in treating a disease in a subject includes providing an antibody, the antibody being a classic antibody or a modified biologic molecule that blocks a first target in the subject; providing a drug, the drug being a small molecule agent that blocks the first target or a second target in the subject; connecting the antibody and the drug with a linker to form an Antibody-Drug Synergism (ADS) compound; and treating the disease with the ADS compound. The linker is hydrolyzed in the subject over a certain time so that both the antibody and the drug exert their functions simultaneously, and the ADS compound confers better efficacy than either the antibody or the drug alone due to a synergism of the ADS compound.


Find Patent Forward Citations

Loading…